These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18095806)

  • 1. The prevalence and management of chronic pain in end-stage renal disease.
    Davison SN
    J Palliat Med; 2007 Dec; 10(6):1277-87. PubMed ID: 18095806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic pain in end-stage renal disease.
    Davison SN
    Adv Chronic Kidney Dis; 2005 Jul; 12(3):326-34. PubMed ID: 16010647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Opioid analgesics in patients with chronic renal failure: principles for use and current guidelines].
    Niscola P; Giovannini M; Vischini G; Scaramucci L; Ferrannini M; Tendas A; Cupelli L; Bondanini F; Di Daniele N; Palumbo R
    G Ital Nefrol; 2011; 28(3):269-77. PubMed ID: 21626495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptoms and their correlates in chronic kidney disease.
    Weisbord SD
    Adv Chronic Kidney Dis; 2007 Oct; 14(4):319-27. PubMed ID: 17904498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achieving effective pain relief in patients with chronic kidney disease: a review of analgesics in renal failure.
    Nayak-Rao S
    J Nephrol; 2011; 24(1):35-40. PubMed ID: 20383865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Approach to Pain Management in End Stage Renal Disease: Considerations for General Management and Intradialytic Symptoms.
    Koncicki HM; Brennan F; Vinen K; Davison SN
    Semin Dial; 2015; 28(4):384-91. PubMed ID: 25864854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pain management in older adults.
    Tracy B; Sean Morrison R
    Clin Ther; 2013 Nov; 35(11):1659-68. PubMed ID: 24148553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of opioid analgesia in end-stage renal disease patients managed without dialysis: recommendations for practice.
    Murtagh FE; Chai MO; Donohoe P; Edmonds PM; Higginson IJ
    J Pain Palliat Care Pharmacother; 2007; 21(2):5-16. PubMed ID: 17844723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pain management at the end of life in a patient with renal failure.
    Daines PA
    CANNT J; 2004; 14(2):20-3, 26-9; quiz 24-5, 30-1. PubMed ID: 15509029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pain in chronic kidney disease: prevalence, cause and management.
    Kafkia T; Chamney M; Drinkwater A; Pegoraro M; Sedgewick J
    J Ren Care; 2011 Jun; 37(2):114-22. PubMed ID: 21561548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain management in chronic kidney disease: the pharmacokinetics and pharmacodynamics of hydromorphone and hydromorphone-3-glucuronide in hemodialysis patients.
    Davison SN; Mayo PR
    J Opioid Manag; 2008; 4(6):335-6, 339-44. PubMed ID: 19192761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the world health organization analgesic ladder to treat pain in end-stage renal disease.
    Barakzoy AS; Moss AH
    J Am Soc Nephrol; 2006 Nov; 17(11):3198-203. PubMed ID: 16988057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a legitimate role for the therapeutic use of cannabinoids for symptom management in chronic kidney disease?
    Davison SN; Davison JS
    J Pain Symptom Manage; 2011 Apr; 41(4):768-78. PubMed ID: 21269798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables.
    Manchikanti L; Cash KA; Damron KS; Manchukonda R; Pampati V; McManus CD
    Pain Physician; 2006 Jul; 9(3):215-25. PubMed ID: 16886030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A structured literature review of pain assessment and management of patients with chronic kidney disease.
    Williams A; Manias E
    J Clin Nurs; 2008 Jan; 17(1):69-81. PubMed ID: 17608633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meeting the challenges of opioid-induced constipation in chronic pain management - a novel approach.
    Reimer K; Hopp M; Zenz M; Maier C; Holzer P; Mikus G; Bosse B; Smith K; Buschmann-Kramm C; Leyendecker P
    Pharmacology; 2009; 83(1):10-7. PubMed ID: 18957874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calciphylaxis: case report and literature review.
    Somorin AO; Al Harbi A; Subaity Y; Zaman AU
    Afr J Med Med Sci; 2002 Jun; 31(2):175-8. PubMed ID: 12518918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal osteodystrophy--oral changes in chronic, end-stage renal insufficiency and long-term hemodialysis].
    Legarth J
    Tandlaegebladet; 1983 May; 87(8):269-73. PubMed ID: 6225201
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone mineral density in chronic renal insufficiency and end-stage renal disease: how to interpret the scans.
    Chesney RW
    J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1327-32. PubMed ID: 15506079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.